Cargando…
Appropriate selection for omalizumab treatment in patients with severe asthma?
Background: Omalizumab improves asthma control in patients with uncontrolled severe allergic asthma; however, appropriate patient selection is crucial. Information in this field is sparse. Objective: We aimed to estimate whether potential omalizumab candidates were appropriately selected according t...
Autores principales: | Nygaard, Leo, Henriksen, Daniel Pilsgaard, Madsen, Hanne, Davidsen, Jesper Rømhild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553102/ https://www.ncbi.nlm.nih.gov/pubmed/28815007 http://dx.doi.org/10.1080/20018525.2017.1359477 |
Ejemplares similares
-
Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis
por: Davidsen, Jesper Rømhild, et al.
Publicado: (2020) -
Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma
por: Prætorius, Katrine, et al.
Publicado: (2021) -
Does point-of-care ultrasonography cause discomfort in patients admitted with respiratory symptoms?
por: Laursen, Christian B., et al.
Publicado: (2015) -
Diagnostic performance of chest X-ray for the diagnosis of community acquired pneumonia in acute admitted patients with respiratory symptoms
por: Laursen, Christian B, et al.
Publicado: (2013) -
Trends and predictors of specialist assessments in oral corticosteroid treated asthma among young adults
por: Skov, Inge Raadal, et al.
Publicado: (2022)